Target intelligence / Profile preview

RHO family interacting cell polarization regulator 2 (RIPOR2)

Target
RIPOR2
Molecular classification
Other (RHOA-binding adaptor/inhibitor)
01

Overview

RHO family interacting cell polarization regulator 2 (RIPOR2) is an adaptor and inhibitor protein that directly binds RHOA GTPase and suppresses its activity, thus playing a key role in cell migration, polarization, and cytoskeletal organization[1][3]. It is essential for several biological processes: it regulates T cell and neutrophil migration and polarization via RHOA inhibition, acts as a negative regulator of cell proliferation, and influences skeletal muscle cell differentiation and myoblast fusion[1][3]. In the auditory system, RIPOR2 is necessary for the development and maintenance of hair cell stereocilia; its loss causes non-syndromic hereditary deafness due to defects in hair cell bundle structure[3][4]. RIPOR2 activity is tightly regulated by upstream kinases and it integrates signals for immune cell migration, myogenesis, and autophagy in a context-dependent manner[1][3]. No direct therapeutic agents targeting RIPOR2 are currently known; however, its genetic variants serve as biomarkers in the diagnosis of hereditary deafness syndromes[3][4].

Other names
C6orf32DIFF48FAM65BKIAA0386PL48MYONAPDFNA21DFNB104DIFF40family with sequence similarity 65 member Bmyogenesis-related and NCAM-associated protein homologprotein FAM65B
02

Biological functions

Inhibition of RHOA GTPase signaling (RHOA inhibitor)Regulation of T cell adhesion, migration, and polarizationNegative regulation of cell proliferationRegulation of muscle cell differentiation and fusion (myogenesis)Inhibition of autophagyMaintenance of hair cell stereocilia structure (hearing)
03

Disease associations

Hearing loss (autosomal dominant and recessive forms)Possible roles in immune dysfunction (T cell migration, neutrophil polarization)Muscle differentiation defects (potential for muscle disease)
04

Safety considerations

Loss-of-function leads to hereditary deafness[3][4]Dysregulation may impact immune cell migration and myogenesis[1]
05

Biomarkers

Mutations in RIPOR2 for genetic forms of hearing loss (DFNA21, DFNB104)[3][4]

Beyond the preview

Go deeper on RHO family interacting cell polarization regulator 2 (RIPOR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RHO family interacting cell polarization regulator 2 (RIPOR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call